<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03436472</url>
  </required_header>
  <id_info>
    <org_study_id>Dex-5-2016</org_study_id>
    <nct_id>NCT03436472</nct_id>
  </id_info>
  <brief_title>Dexmedetomidine and 5-year Outcome in Elderly Patients After Surgery</brief_title>
  <official_title>Impact of Dexmedetomidine on Long-term Outcome in Elderly Patients After Noncardiac Surgery: 5-year Follow-up of a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University First Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Peking University Third Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Peking University First Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Delirium is a frequent postoperative complication. Its occurrence is associated with worse
      long-term outcomes. In a previous randomized controlled trial, prophylactic low-dose
      dexmedetomidine infusion during the early postoperative period decreased the incidence of
      delirium in elderly patients after surgery. The purpose of this 5-year follow-up study is to
      evaluate whether prophylactic low-dose dexmedetomidine infusion can improve the 5-year
      outcomes in elderly patients recruited in the previous randomized controlled trial.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Delirium is a frequent postoperative complication; a systematic review revealed that
      postoperative delirium occurs in 36.8% of surgical patients, and its prevalence increases
      with age. The occurrence of delirium is associated with worse long-term outcomes including
      worse functional recovery, decline in cognitive function, and increased mortality rate.
      Surgical stress, pain, and sleep disturbances are important factors leading to postoperative
      delirium in the elderly.

      Dexmedetomidine is a highly selective alpha-2 adrenoreceptor agonist that provides
      anti-anxiety, sedation, and modest analgesia with minimal respiratory depression. For
      mechanically ventilated intensive care unit (ICU) patients, dexmedetomidine sedation improves
      the quality of sleep, decreases the incidence of delirium, and shortens the duration of ICU
      stay. For patients undergoing surgery, perioperative dexmedetomidine relieves the severity of
      stress response, decreases the requirement of anesthetics, and improves postoperative
      analgesia.

      In the previous stage of the current study, 700 elderly patients who were admitted to the ICU
      after noncardiac surgery were recruited and randomized into two groups (dexmedetomidine group
      and placebo [normal saline] group). The results showed that prophylactic low-dose
      dexmedetomidine infusion during the early postoperative period ameliorated the subjective
      sleep quality and decreased the incidence of delirium (22.6% [79/350] with placebo vs. 9.1%
      [32/350] with dexmedetomidine; odds ratio 0.35, 95% confidence interval 0.22 to 0.54; p &lt;
      0.0001). The investigators hypothesize that low-dose dexmedetomidine infusion may also
      improve long-term outcome in this patient population.

      The purpose of this 5-year follow-up study is to evaluate whether prophylactic low-dose
      dexmedetomidine infusion during the early postoperative period can improve the 5-year
      outcomes in elderly patients recruited in the previous randomized controlled trial.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">August 17, 2011</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Parallel Assignment</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of 5-year survival after surgery</measure>
    <time_frame>From the day of surgery until the end of the 5th year after surgery</time_frame>
    <description>Duration of 5-year survival after surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Survival rates after surgery</measure>
    <time_frame>At 6 months, 1 year, 2 years ,3 years, 4 years,and 5 years after surgery</time_frame>
    <description>Survival rates at different timepoints after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive function in 5-year survivors after surgery</measure>
    <time_frame>At the end of the 5th year after surgery</time_frame>
    <description>Cognitive function is assessed with Telephone Interview for Cognitive Status-Modified (TICS-M).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health related quality of life in 5-year survivors after surgery</measure>
    <time_frame>At the end of the 5th year after surgery</time_frame>
    <description>Health related quality of life is assessed with World Health Organization Quality of Life-BREF (WHOQOL-BREF).</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Survival rates in the subgroup of patients after cancer or non-cancer surgery</measure>
    <time_frame>At 6 months, 1 year, 2 years, 3 years, 4 years, and 5 years after surgery</time_frame>
    <description>Survival rates at different time-points in the subgroup of patients after cancer or non-cancer surgery</description>
  </other_outcome>
  <other_outcome>
    <measure>Duration of survival in the subgroup of patients after cancer or non-cancer surgery</measure>
    <time_frame>From the day of surgery until the end of the 5th year after surgery</time_frame>
    <description>Duration of survival in the subgroup of patients after cancer or non-cancer surgery</description>
  </other_outcome>
  <other_outcome>
    <measure>Cognitive function in the subgroup of 5-year survivors after cancer or non-cancer surgery</measure>
    <time_frame>At the end of the 5th year after surgery</time_frame>
    <description>Cognitive function is assessed with Telephone Interview for Cognitive Status-Modified (TICS-M)</description>
  </other_outcome>
  <other_outcome>
    <measure>Health related quality of life in the subgroup of 5-year survivors after cancer or non-cancer surgery</measure>
    <time_frame>At the end of the 5th year after surgery</time_frame>
    <description>Health related quality of life is assessed with World Health Organization Quality of Life-BREF (WHOQOL-BREF).</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">700</enrollment>
  <condition>Aged</condition>
  <condition>Operative</condition>
  <condition>Delirium</condition>
  <condition>Dexmedetomidine</condition>
  <condition>Mortality</condition>
  <condition>Long-term Survivors</condition>
  <arm_group>
    <arm_group_label>dexmedetomidine group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>For patients who were not intubated, dexmedetomidine was infused at a rate of 0.1 microgram/kg per hour from study recruitment on the day of surgery until 8:00 am on the first day after surgery. For patients who were intubated and mechanically ventilated, dexmedetomidine infusion was started after the Richmond Agitation Sedation Scale was -2 or higher after intensive care unit admission until 8:00 am on the first day after surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Normal saline was infused in the same rate for the same duration as that in the placebo group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dexmedetomidine</intervention_name>
    <description>low-dose dexmedetomidine infusion</description>
    <arm_group_label>dexmedetomidine group</arm_group_label>
    <other_name>dexmedetomidine hydrochloride</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>normal saline infusion</description>
    <arm_group_label>placebo group</arm_group_label>
    <other_name>normal saline</other_name>
    <other_name>0.9% sodium chloride</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients were included if they met all of the following criteria:

          -  Age of 65 years or older;

          -  Underwent elective noncardiac surgery under general anesthesia;

          -  Admitted to ICU after surgery.

        Exclusion Criteria:

        Patients were excluded if they met any of the following criteria:

          -  Preoperative history of schizophrenia, epilepsy, Parkinsonism or myasthenia gravis;

          -  Inability to communicate in the preoperative period (because of coma, profound
             dementia or language barrier);

          -  Brain injury or neurosurgery;

          -  Preoperative left ventricular ejection fraction &lt; 30%, sick sinus syndrome, severe
             sinus bradycardia (&lt; 50 beats per minute), or second-degree or greater
             atrioventricular block without pacemaker;

          -  Serious hepatic dysfunction (Child-Pugh class C);

          -  Serious renal dysfunction (undergoing dialysis before surgery); or

          -  Unlikely to survive for more than 24 hours.
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dong-Xin Wang, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Peking University First Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Peking University First Hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100034</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Rabe-Jabłońska J, Bieńkiewicz W. [Anxiety disorders in the fourth edition of the classification of mental disorders prepared by the American Psychiatric Association: diagnostic and statistical manual of mental disorders (DMS-IV -- options book]. Psychiatr Pol. 1994 Mar-Apr;28(2):255-68. Polish.</citation>
    <PMID>8208869</PMID>
  </reference>
  <reference>
    <citation>Dyer CB, Ashton CM, Teasdale TA. Postoperative delirium. A review of 80 primary data-collection studies. Arch Intern Med. 1995 Mar 13;155(5):461-5. Review.</citation>
    <PMID>7864702</PMID>
  </reference>
  <reference>
    <citation>Girard TD, Pandharipande PP, Ely EW. Delirium in the intensive care unit. Crit Care. 2008;12 Suppl 3:S3. doi: 10.1186/cc6149. Epub 2008 May 14. Review.</citation>
    <PMID>18495054</PMID>
  </reference>
  <reference>
    <citation>Mu DL, Wang DX, Li LH, Shan GJ, Li J, Yu QJ, Shi CX. High serum cortisol level is associated with increased risk of delirium after coronary artery bypass graft surgery: a prospective cohort study. Crit Care. 2010;14(6):R238. doi: 10.1186/cc9393. Epub 2010 Dec 30.</citation>
    <PMID>21192800</PMID>
  </reference>
  <reference>
    <citation>Shi CM, Wang DX, Chen KS, Gu XE. Incidence and risk factors of delirium in critically ill patients after non-cardiac surgery. Chin Med J (Engl). 2010 Apr 20;123(8):993-9.</citation>
    <PMID>20497703</PMID>
  </reference>
  <reference>
    <citation>Roberts B, Rickard CM, Rajbhandari D, Turner G, Clarke J, Hill D, Tauschke C, Chaboyer W, Parsons R. Multicentre study of delirium in ICU patients using a simple screening tool. Aust Crit Care. 2005 Feb;18(1):6, 8-9, 11-4 passim.</citation>
    <PMID>18038529</PMID>
  </reference>
  <reference>
    <citation>Balas MC, Happ MB, Yang W, Chelluri L, Richmond T. Outcomes Associated With Delirium in Older Patients in Surgical ICUs. Chest. 2009 Jan;135(1):18-25. doi: 10.1378/chest.08-1456. Epub 2008 Nov 18.</citation>
    <PMID>19017895</PMID>
  </reference>
  <reference>
    <citation>Ely EW, Gautam S, Margolin R, Francis J, May L, Speroff T, Truman B, Dittus R, Bernard R, Inouye SK. The impact of delirium in the intensive care unit on hospital length of stay. Intensive Care Med. 2001 Dec;27(12):1892-900. Epub 2001 Nov 8.</citation>
    <PMID>11797025</PMID>
  </reference>
  <reference>
    <citation>Ansaloni L, Catena F, Chattat R, Fortuna D, Franceschi C, Mascitti P, Melotti RM. Risk factors and incidence of postoperative delirium in elderly patients after elective and emergency surgery. Br J Surg. 2010 Feb;97(2):273-80. doi: 10.1002/bjs.6843.</citation>
    <PMID>20069607</PMID>
  </reference>
  <reference>
    <citation>Ely EW, Shintani A, Truman B, Speroff T, Gordon SM, Harrell FE Jr, Inouye SK, Bernard GR, Dittus RS. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA. 2004 Apr 14;291(14):1753-62.</citation>
    <PMID>15082703</PMID>
  </reference>
  <reference>
    <citation>Franco K, Litaker D, Locala J, Bronson D. The cost of delirium in the surgical patient. Psychosomatics. 2001 Jan-Feb;42(1):68-73.</citation>
    <PMID>11161124</PMID>
  </reference>
  <reference>
    <citation>Milbrandt EB, Deppen S, Harrison PL, Shintani AK, Speroff T, Stiles RA, Truman B, Bernard GR, Dittus RS, Ely EW. Costs associated with delirium in mechanically ventilated patients. Crit Care Med. 2004 Apr;32(4):955-62.</citation>
    <PMID>15071384</PMID>
  </reference>
  <reference>
    <citation>Pisani MA, Kong SY, Kasl SV, Murphy TE, Araujo KL, Van Ness PH. Days of delirium are associated with 1-year mortality in an older intensive care unit population. Am J Respir Crit Care Med. 2009 Dec 1;180(11):1092-7. doi: 10.1164/rccm.200904-0537OC. Epub 2009 Sep 10.</citation>
    <PMID>19745202</PMID>
  </reference>
  <reference>
    <citation>Bickel H, Gradinger R, Kochs E, Förstl H. High risk of cognitive and functional decline after postoperative delirium. A three-year prospective study. Dement Geriatr Cogn Disord. 2008;26(1):26-31. doi: 10.1159/000140804. Epub 2008 Jun 24.</citation>
    <PMID>18577850</PMID>
  </reference>
  <reference>
    <citation>Van Rompaey B, Schuurmans MJ, Shortridge-Baggett LM, Truijen S, Elseviers M, Bossaert L. Long term outcome after delirium in the intensive care unit. J Clin Nurs. 2009 Dec;18(23):3349-57. doi: 10.1111/j.1365-2702.2009.02933.x. Epub 2009 Sep 4.</citation>
    <PMID>19735334</PMID>
  </reference>
  <reference>
    <citation>Vaurio LE, Sands LP, Wang Y, Mullen EA, Leung JM. Postoperative delirium: the importance of pain and pain management. Anesth Analg. 2006 Apr;102(4):1267-73.</citation>
    <PMID>16551935</PMID>
  </reference>
  <reference>
    <citation>Halaszynski TM. Pain management in the elderly and cognitively impaired patient: the role of regional anesthesia and analgesia. Curr Opin Anaesthesiol. 2009 Oct;22(5):594-9. doi: 10.1097/ACO.0b013e32833020dc. Review.</citation>
    <PMID>19623056</PMID>
  </reference>
  <reference>
    <citation>Hudek K. Emergence delirium: a nursing perspective. AORN J. 2009 Mar;89(3):509-16; quiz 517-9. Review.</citation>
    <PMID>19326585</PMID>
  </reference>
  <reference>
    <citation>Rudolph JL, Ramlawi B, Kuchel GA, McElhaney JE, Xie D, Sellke FW, Khabbaz K, Levkoff SE, Marcantonio ER. Chemokines are associated with delirium after cardiac surgery. J Gerontol A Biol Sci Med Sci. 2008 Feb;63(2):184-9.</citation>
    <PMID>18314455</PMID>
  </reference>
  <reference>
    <citation>de Rooij SE, van Munster BC, Korevaar JC, Levi M. Cytokines and acute phase response in delirium. J Psychosom Res. 2007 May;62(5):521-5.</citation>
    <PMID>17467406</PMID>
  </reference>
  <reference>
    <citation>Roth-Isigkeit A, Borstel TV, Seyfarth M, Schmucker P. Perioperative serum levels of tumour-necrosis-factor alpha (TNF-alpha), IL-1 beta, IL-6, IL-10 and soluble IL-2 receptor in patients undergoing cardiac surgery with cardiopulmonary bypass without and with correction for haemodilution. Clin Exp Immunol. 1999 Nov;118(2):242-6.</citation>
    <PMID>10540185</PMID>
  </reference>
  <reference>
    <citation>Holmes JH 4th, Connolly NC, Paull DL, Hill ME, Guyton SW, Ziegler SF, Hall RA. Magnitude of the inflammatory response to cardiopulmonary bypass and its relation to adverse clinical outcomes. Inflamm Res. 2002 Dec;51(12):579-86.</citation>
    <PMID>12558191</PMID>
  </reference>
  <reference>
    <citation>Siddiqi N, Stockdale R, Britton AM, Holmes J. Interventions for preventing delirium in hospitalised patients. Cochrane Database Syst Rev. 2007 Apr 18;(2):CD005563. Review. Update in: Cochrane Database Syst Rev. 2016;3:CD005563.</citation>
    <PMID>17443600</PMID>
  </reference>
  <reference>
    <citation>Jorden VSB, et al. Dexmedetomidine: clinical update. Semin Anesth Periop Med Pain 2002;21:265-74.</citation>
  </reference>
  <reference>
    <citation>Iirola T, Aantaa R, Laitio R, Kentala E, Lahtinen M, Wighton A, Garratt C, Ahtola-Sätilä T, Olkkola KT. Pharmacokinetics of prolonged infusion of high-dose dexmedetomidine in critically ill patients. Crit Care. 2011;15(5):R257. doi: 10.1186/cc10518. Epub 2011 Oct 26.</citation>
    <PMID>22030215</PMID>
  </reference>
  <reference>
    <citation>Liu C, Zhang Y, She S, Xu L, Ruan X. A randomised controlled trial of dexmedetomidine for suspension laryngoscopy. Anaesthesia. 2013 Jan;68(1):60-6. doi: 10.1111/j.1365-2044.2012.07331.x. Epub 2012 Oct 29.</citation>
    <PMID>23106186</PMID>
  </reference>
  <reference>
    <citation>Gozalo-Marcilla M, Hopster K, Gasthuys F, Hatz L, Krajewski AE, Schauvliege S. Effects of a constant-rate infusion of dexmedetomidine on the minimal alveolar concentration of sevoflurane in ponies. Equine Vet J. 2013 Mar;45(2):204-8. doi: 10.1111/j.2042-3306.2012.00613.x. Epub 2012 Aug 1.</citation>
    <PMID>22853551</PMID>
  </reference>
  <reference>
    <citation>Bekker A, Haile M, Kline R, Didehvar S, Babu R, Martiniuk F, Urban M. The effect of intraoperative infusion of dexmedetomidine on the quality of recovery after major spinal surgery. J Neurosurg Anesthesiol. 2013 Jan;25(1):16-24. doi: 10.1097/ANA.0b013e31826318af.</citation>
    <PMID>22824921</PMID>
  </reference>
  <reference>
    <citation>Shim JJ, Leung JM. An update on delirium in the postoperative setting: prevention, diagnosis and management. Best Pract Res Clin Anaesthesiol. 2012 Sep;26(3):327-43. doi: 10.1016/j.bpa.2012.08.003. Review.</citation>
    <PMID>23040284</PMID>
  </reference>
  <reference>
    <citation>Park JK, Cheong SH, Lee KM, Lim SH, Lee JH, Cho K, Kim MH, Kim HT. Does dexmedetomidine reduce postoperative pain after laparoscopic cholecystectomy with multimodal analgesia? Korean J Anesthesiol. 2012 Nov;63(5):436-40. doi: 10.4097/kjae.2012.63.5.436. Epub 2012 Nov 16.</citation>
    <PMID>23198038</PMID>
  </reference>
  <reference>
    <citation>Anger KE. Dexmedetomidine: a review of its use for the management of pain, agitation, and delirium in the intensive care unit. Curr Pharm Des. 2013;19(22):4003-13. Review.</citation>
    <PMID>23228319</PMID>
  </reference>
  <reference>
    <citation>Oto J, Yamamoto K, Koike S, Onodera M, Imanaka H, Nishimura M. Sleep quality of mechanically ventilated patients sedated with dexmedetomidine. Intensive Care Med. 2012 Dec;38(12):1982-9. doi: 10.1007/s00134-012-2685-y. Epub 2012 Sep 8.</citation>
    <PMID>22961436</PMID>
  </reference>
  <reference>
    <citation>Oto J, Yamamoto K, Koike S, Imanaka H, Nishimura M. Effect of daily sedative interruption on sleep stages of mechanically ventilated patients receiving midazolam by infusion. Anaesth Intensive Care. 2011 May;39(3):392-400.</citation>
    <PMID>21675058</PMID>
  </reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 12, 2018</study_first_submitted>
  <study_first_submitted_qc>February 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 16, 2018</study_first_posted>
  <last_update_submitted>February 21, 2018</last_update_submitted>
  <last_update_submitted_qc>February 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Peking University First Hospital</investigator_affiliation>
    <investigator_full_name>Dong-Xin Wang</investigator_full_name>
    <investigator_title>Professor and Chairman, Department of Anesthesiology and Critical Care Medicine</investigator_title>
  </responsible_party>
  <keyword>aged</keyword>
  <keyword>operative</keyword>
  <keyword>delirium</keyword>
  <keyword>dexmedetomidine</keyword>
  <keyword>long-term outcome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delirium</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Data will be provided on request.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

